Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seasonale not threatened by Librel

Executive Summary

Wyeth's Librel, a "continuous-use" oral contraceptive in development, will not compete directly with Barr's 91-day regimen OC Seasonale, Barr says. "Our market research shows women prefer the quarterly product," CEO Bruce Downey said on a company conference call Nov. 4. However, "there is a minority of women who prefer a longer cycle, and that also shows up in the market research...Overall, incremental promotion of other extended regimen products will increase the category and it will benefit both Barr's products and Wyeth's products"...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS044947

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel